# Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy

> **NCT06948396** · — · ACTIVE_NOT_RECRUITING · sponsor: **AstraZeneca** · enrollment: 315 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** Tezepelumab

## Key facts

- **NCT ID:** NCT06948396
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-25
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-05-30
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06948396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06948396, "Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06948396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*